These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 18772059)

  • 21. Intensive multifactorial intervention for stable coronary artery disease: optimal medical therapy in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial.
    Maron DJ; Boden WE; O'Rourke RA; Hartigan PM; Calfas KJ; Mancini GB; Spertus JA; Dada M; Kostuk WJ; Knudtson M; Harris CL; Sedlis SP; Zoble RG; Title LM; Gosselin G; Nawaz S; Gau GT; Blaustein AS; Bates ER; Shaw LJ; Berman DS; Chaitman BR; Weintraub WS; Teo KK;
    J Am Coll Cardiol; 2010 Mar; 55(13):1348-58. PubMed ID: 20338496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is there evidence for prognostic benefit following PCI in stable patients? COURAGE and its implications: an interventionalist's view.
    Curzen NP
    Heart; 2010 Jan; 96(2):103-5. PubMed ID: 19778925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Strategy for patients with low-risk coronary artery disease: initial medical therapy only or PCI plus medical therapy].
    Nishigaki K
    Nihon Rinsho; 2011 Feb; 69(2):253-8. PubMed ID: 21387672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economics methods in the Clinical Outcomes Utilizing percutaneous coronary Revascularization and Aggressive Guideline-driven drug Evaluation (COURAGE) trial.
    Weintraub WS; Barnett P; Chen S; Hartigan P; Casperson P; O'Rourke R; Boden WE; Lewis C; Veledar E; Becker E; Culler S; Kolm P; Mahoney EM; Dunbar SB; Deaton C; O'Brien B; Goeree R; Blackhouse G; Nease R; Spertus J; Kaufman S; Teo K
    Am Heart J; 2006 Jun; 151(6):1180-5. PubMed ID: 16781215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistent reservations against contradicted percutaneous coronary intervention indications: citation content analysis.
    Siontis GC; Tatsioni A; Katritsis DG; Ioannidis JP
    Am Heart J; 2009 Apr; 157(4):695-701. PubMed ID: 19332198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meta-analysis: effects of percutaneous coronary intervention versus medical therapy on angina relief.
    Wijeysundera HC; Nallamothu BK; Krumholz HM; Tu JV; Ko DT
    Ann Intern Med; 2010 Mar; 152(6):370-9. PubMed ID: 20231568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Stable ischemic coronary disease--medical therapy or PCI?].
    Mickley H; Egstrup K
    Ugeskr Laeger; 2007 Jun; 169(23):2227. PubMed ID: 17607849
    [No Abstract]   [Full Text] [Related]  

  • 28. Current indications for percutaneous coronary intervention for chronic stable angina: implications of the COURAGE Trial.
    Kiernan TJ; Prasad A; Gersh BJ
    Rev Cardiovasc Med; 2007; 8(4):234-9. PubMed ID: 18192947
    [No Abstract]   [Full Text] [Related]  

  • 29. HRQoL after coronary artery bypass grafting and percutaneous coronary intervention for stable angina.
    Loponen P; Luther M; Korpilahti K; Wistbacka JO; Huhtala H; Laurikka J; Tarkka MR
    Scand Cardiovasc J; 2009 Apr; 43(2):94-9. PubMed ID: 18819033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indications for coronary artery bypass surgery and percutaneous coronary intervention in chronic stable angina: review of the evidence and methodological considerations.
    Rihal CS; Raco DL; Gersh BJ; Yusuf S
    Circulation; 2003 Nov; 108(20):2439-45. PubMed ID: 14623791
    [No Abstract]   [Full Text] [Related]  

  • 31. Coronary artery bypass surgery versus percutaneous coronary artery intervention in patients on chronic hemodialysis: does a drug-eluting stent have an impact on clinical outcome?
    Manabe S; Shimokawa T; Fukui T; Fumimoto KU; Ozawa N; Seki H; Takanashi S
    J Card Surg; 2009; 24(3):234-9. PubMed ID: 19438773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of long-term statin treatment on coronary plaque composition at angiographically severe lesions: a nonrandomized study of the history of long-term statin treatment before coronary angioplasty.
    Miyagi M; Ishii H; Murakami R; Isobe S; Hayashi M; Amano T; Arai K; Ohashi T; Uetani T; Matsubara T; Murohara T
    Clin Ther; 2009 Jan; 31(1):64-73. PubMed ID: 19243707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of I(f) inhibition with ivabradine in different subpopulations with stable angina pectoris.
    Tendera M; Borer JS; Tardif JC
    Cardiology; 2009; 114(2):116-25. PubMed ID: 19468225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [COURAGE Study shows: angina pectoris despite optimal therapy. Nonetheless, every 4th patient suffers despite drugs and PCI from angina pectoris attacks].
    Gerdts KG
    MMW Fortschr Med; 2008 Jun; 150(26-27):28-9. PubMed ID: 18681227
    [No Abstract]   [Full Text] [Related]  

  • 35. Current analysis of the results of the COURAGE trial: has an optimal treatment been reached in clinical practice?
    Asín Cardiel E; Murga N
    Am J Cardiovasc Drugs; 2009; 9 Suppl 1():19-21. PubMed ID: 20000884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of stress testing prior to percutaneous coronary intervention in patients with stable coronary artery disease.
    Lin GA; Redberg RF
    Expert Rev Cardiovasc Ther; 2009 Sep; 7(9):1061-6. PubMed ID: 19764859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of long-term mortality after percutaneous coronary intervention in patients treated for acute ST-elevation myocardial infarction versus those with unstable and stable angina pectoris.
    Hirsch A; Verouden NJ; Koch KT; Baan J; Henriques JP; Piek JJ; Rohling WJ; van der Schaaf RJ; Tijssen JG; Vis MM; de Winter RJ
    Am J Cardiol; 2009 Aug; 104(3):333-7. PubMed ID: 19616663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors affecting post minimally invasive direct coronary artery bypass grafting incidence of myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting and mortality of cardiac origin.
    Kofidis T; Gerd Paeschke H; Lichtenberg A; Emmert M; Woitek F; Didilis V; Haverich A; Klima U
    Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):49-53. PubMed ID: 18786942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Optimal medical therapy is the treatment of choice for stable chronic coronary disease].
    Gielen S
    Dtsch Med Wochenschr; 2010 Oct; 135(39):1937. PubMed ID: 20839157
    [No Abstract]   [Full Text] [Related]  

  • 40. [Evidence-based optimal treatment strategy of patients with angina pectoris].
    Jánosi A
    Orv Hetil; 2008 Feb; 149(7):293-8. PubMed ID: 18258559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.